1.91 USD
+0.03 (+1.6%)
ChartMill assigns a Buy % Consensus number of 83% to GDTC. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 5.1. This target is 167.02% above the current price.
GDTC was analyzed by 7 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about GDTC.
In the previous month the buy percentage consensus was at a similar level.
GDTC was analyzed by 7 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-10-10 | Benchmark | Reiterate | Speculative Buy -> Speculative Buy |
| 2024-06-11 | Benchmark | Reiterate | Speculative Buy -> Speculative Buy |
| 2023-12-04 | Benchmark | Reiterate | Speculative Buy -> Speculative Buy |
| 2023-07-21 | Benchmark | Initiate | Speculative Buy |
CYTOMED THERAPEUTICS LTD / GDTC FAQ
Can you provide the average price target for CYTOMED THERAPEUTICS LTD stock?
7 analysts have analysed GDTC and the average price target is 5.1 USD. This implies a price increase of 167.02% is expected in the next year compared to the current price of 1.91.
What is the consensus rating for CYTOMED THERAPEUTICS LTD (GDTC) stock?
The consensus rating for CYTOMED THERAPEUTICS LTD (GDTC) is 82.8571 / 100 . This indicates that analysts generally have a positive outlook on the stock.
What is the number of analysts for GDTC stock?
The number of analysts covering CYTOMED THERAPEUTICS LTD (GDTC) is 7.